PE Fund Investments
ChrysCap buys 8% stake in generics pharma co La Renon for Rs.600-Cr
ChrysCapital has invested about INR 600 crore (USD 70 million) in Ahmedabad-based La Renon Healthcare, valuing it at USD 800 million (INR 6,500 crore). ChrysCap has acquired about 8% stake from the promoter family in a secondary transaction.Incorporated in 2007 by Pankaj Singh, La Renon is engaged in the manufacturing and marketing of branded generic formulations. La Renon claims to offer solutions for a range of chronic disease management in India and 40 different countries. The major segments the firm caters to are Nephrology, Neurological Disorders, Critical Care, Gynaecology, Ortho, Gastroenterology, Urology, Respiratory and Cardio Metabolic.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
